Abstract:Type 1 diabetes (T1D) results from the autoimmune destruction of pancreatic insulin-producing β-cells, primarily targeted by autoreac-tive T cells that recognize insulin B9-23 peptides as antigens. Using drift tube ion mobility spectrometry-mass spectrometry (DT-IMS), transmission electron microscopy (TEM), and two-dimensional infrared spectroscopy (2D IR), we characterized mouse insulin 1 B9-23 (Ins1 B9-23), insulin 2 B9-23 (Ins2 B9-23), along with two of their mutants, Ins2 B9-23 Y16A and Ins2 B9-23 C19S. We focus on two competing factors that may affect the aggregation kinetics of B9-23 variants: (a) the formation of intermolecular disulfide bonds by C19 which stabilizes parallel β-sheet assembly, and (b) the aggregation of B12-17 (VEALYL) which favors anti-parallel sheets. Their interplay likely contributes to the observed variations in aggregation kinetics and morphologies. Our findings indicate that Ins1 B9-23 and the Ins2 Y16A mutant exhibit rapid fibril formation, whereas Ins2 B9-23 and the Ins2 C19S mutant show slower fibrilization and a structural rearrangement from globular protofibrils to fibrillar aggregates. The Y16A mutation decreases the amyloidogenicity of the VEALYL sequence and, thus, indirectly promotes parallel β-sheet arrangements. The weak or lack of disulfide bond formation in Ins2 B9-23 and C19S, respectively, weakens the overall propensity of parallel β-sheet assembly. These differences in aggregation behaviors also manifest in interactions with (-)epigallocatechin gallate (EGCG), a canonical amyloid inhibitor. EGCG effectively disrupts the fibrils formed by Ins1 B9-23 and the Y16A mutant. However, it proves ineffective in preventing fibril formation of Ins2 B9-23 and the C19S mutant. These results establish a strong correlation between the aggregation behaviors of these peptides and their divergent effects on anti-islet autoimmunity.

Characteristic, Activity and Conformational Studies of [A6-Ser, A11-Ser]-insulin.

Intra-A Chain Disulfide Bond (A6-11) of Insulin is Essential for Displaying Its Activity

Flexibility Exists in the Region of [A6-A11, A7-B7] Disulfide Bonds During Insulin Precursor Folding.

Effects of Deletion and Shift of the A20-B19 Disulfide Bond on the Structure, Activity, and Refolding of Proinsulin.

Insulin and Its Single-Chain Analogue

Influence of A7-B7 disulfide bond deletion on the refolding and structure of proinsulin

Hydroxyl Group of Insulin A19Tyr is Essential for Receptor Binding: Studies on (a19phe) Insulin

CONSTRUCTION AND EXPRESSION OF INTRA-A CHAIN DISULFIDE BOND SHIFT MUTANT IN HUMAN PROINSULIN GENE

Separation and Characterization of Trypsin and Carboxypeptidase B-Digested Products of Met-Lys-Human Proinsulin

Purification and Characterization of B_23-Gly-B_24 Human Insulin

(A6,A11)-MUTANT PROINSULIN AS A SCAFFOLD FOR PRESENTING EXOGENOUS FUNCTIONAL-MOTIFS

Construction of Met-Lys-double-C peptide human proinsulin gene and its expression and characterization

Inhibition of Platelet Aggregation of A Mutant Proinsulin Molecule Engineered by Introduction of A Native Arg-Gly-Asp Sequence

Efects of Deleting A19 Tyrosine Form Insulin

Deciphering the Molecular Dance: Exploring the Dynamic Interplay Between Mouse Insulin B9-23 Peptides and Their Variants

Effect of disulfide bond on the conformation and anticoagulant activity of an Arg-Gly-Asp motif displayed on a mutant insulin protein framework

Comparative Study of High-resolution LysB29(Nε-myristoyl) des(B30) Insulin Structures Display Novel Dynamic Causal Interrelations in Monomeric-Dimeric Motions

The Dynamics and Infrared Spectrocopy of Monomeric and Dimeric Wild Type and Mutant Insulin

X-ray Crystallographic and Hydrogen Deuterium Exchange Studies Confirm Alternate Kinetic Models for Homolog Insulin Monomers

Platelet aggregation inhibitory activity of mutant proinsulin with C-peptide replaced by CRGDSC sequence

Structural studies on des-pentapeptide (B26-30)-insulin. V. High resolution NMR studies